KalVista Pharmaceuticals (KALV) Short term Debt (2014 - 2016)

KalVista Pharmaceuticals' Short term Debt history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2016.

• In Q1 2016, Short term Debt rose 81.4% year-over-year to $2.0 million; the TTM figure through Mar 2016 stood at $2.0 million (up 81.4% YoY), while the FY2016 annual figure was $127000.0, changed N/A from the prior year.
• Short term Debt came in at $2.0 million for Q1 2016 at KalVista Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.4 million in Q4 2014 to a low of $480000.0 in Q2 2015.
• A 3-year average of $1.7 million and a median of $1.3 million in 2015 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt sank 67.19% in 2015 and jumped 81.4% in 2016, its largest moves.
• KalVista Pharmaceuticals' Short term Debt stood at $4.4 million in 2014, then tumbled by 67.19% to $1.5 million in 2015, then soared by 34.02% to $2.0 million in 2016.
• According to Business Quant data, Short term Debt over the past three periods registered $2.0 million, $1.5 million, and $965000.0 for Q1 2016, Q4 2015, and Q3 2015 respectively.

Peer Comparison